Nanoviricides Inc's Comment on Sales, Marketing and Customers
The company develops nanoviricides™, a class of drugs utilizing nanomedicine technologies to target viral diseases. Their technology is designed to create drugs that viruses are unlikely to evade due to their host-mimetic structure. These drugs are intended to be safe, tolerable, and effective for all patient populations, including infants, pediatrics, adults, and seniors, without reliance on a healthy immune system. The company's first clinical-stage drug candidate, NV-387, has completed Phase Ia/Ib human clinical trials assessing safety and tolerability in healthy adult subjects. NV-387 serves as the active ingredient in two drug formulations, NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies, developed for the treatment of COVID-19 infection. The company has identified SIGA as a customer in its filings.
Nanoviricides Inc’s Comment on Sales, Marketing and Customers
The company develops nanoviricides™, a class of drugs utilizing nanomedicine technologies to target viral diseases. Their technology is designed to create drugs that viruses are unlikely to evade due to their host-mimetic structure. These drugs are intended to be safe, tolerable, and effective for all patient populations, including infants, pediatrics, adults, and seniors, without reliance on a healthy immune system. The company's first clinical-stage drug candidate, NV-387, has completed Phase Ia/Ib human clinical trials assessing safety and tolerability in healthy adult subjects. NV-387 serves as the active ingredient in two drug formulations, NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies, developed for the treatment of COVID-19 infection. The company has identified SIGA as a customer in its filings.
Sources:
Nanoviricides inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Nanoviricides inc’s corporate clients.
For your research, we’ve provided 9 tables on Nanoviricides inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
